Innate Pharma SA-Spons ADRIPHA
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 10 institutions reported holding Innate Pharma SA-Spons ADR (IPHA) in their 13F filings, up 1 from Q4 2024. 3 opened new positions and 2 sold out. The largest holders were Exchange Traded Concepts, LLC ($112K), Morgan Stanley ($77K) and Citadel Advisors ($43K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Innate Pharma SA-Spons ADR
- CUSIP
- 45781K204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $31K |
| Exits | 2 | $1K |
All 13F filers, Q4 2024 → Q1 2025: 35,467 shares bought and 15,248 shares sold, net +20,219 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Exchange Traded Concepts, LLC | 0.00% | Reduce -18.9% | 62,752 | $112K |
| Morgan Stanley | 0.00% | No change | 43,524 | $77K |
| Citadel Advisors | 0.00% | Add +104.7% | 24,267 | $43K |
| Millennium Management | 0.00% | New | 15,326 | $27K |
| UBS Group AG | 0.00% | Add +156.4% | 9,001 | $16K |
| GAMMA Investing LLC | 0.00% | New | 2,233 | $4K |
| Rhumbline Advisers | 0.00% | No change | 675 | $1K |
| Barclays PLC | 0.00% | No change | 307 | $546 |
| Optiver Holding B.V. | 0.00% | No change | 101 | $180 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3 | $5 |
"% of holder's portfolio" is IPHA's weight in each manager's 13F, not the share of Innate Pharma SA-Spons ADR the manager owns.